John Fromson
Director/Board Member at NeuroTargets Ltd.
John Fromson active positions
| Companies | Position | Start | End |
|---|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Director/Board Member | - | - |
Career history of John Fromson
Former positions of John Fromson
| Companies | Position | Start | End |
|---|---|---|---|
Generis Capital Partners SAS
 Generis Capital Partners SAS Investment ManagersFinance Generis Capital Partners SAS (GCP) is an independent venture capital and private equity firm founded in 2008 by Thibaut de Roux. The firm is headquartered in Paris, France. | Private Equity Investor | 2010-03-31 | 2010-12-30 |
Ultrafine Ltd. (Gillingham)
 Ultrafine Ltd. (Gillingham) Miscellaneous Commercial ServicesCommercial Services Ultrafine Ltd. researches and develops chemical compounds. The company was founded on March 12, 2004 and is headquartered in Gillingham, the United Kingdom. | Chairman | - | - |
| Vanguard Medica Plc | Corporate Officer/Principal | - | - |
Innovata Ltd.
 Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | - | - |
Statistics
International
| United Kingdom | 5 |
| France | 2 |
Operational
| Director/Board Member | 2 |
| Chairman | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Health Technology |
Innovata Ltd.
Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Ultrafine Ltd. (Gillingham)
Ultrafine Ltd. (Gillingham) Miscellaneous Commercial ServicesCommercial Services Ultrafine Ltd. researches and develops chemical compounds. The company was founded on March 12, 2004 and is headquartered in Gillingham, the United Kingdom. | Commercial Services |
| Vanguard Medica Plc | Commercial Services |
Generis Capital Partners SAS
Generis Capital Partners SAS Investment ManagersFinance Generis Capital Partners SAS (GCP) is an independent venture capital and private equity firm founded in 2008 by Thibaut de Roux. The firm is headquartered in Paris, France. | Finance |
- Stock Market
- Insiders
- John Fromson
- Experience
